Stockach, Germany

Thomas Maier

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 128(Granted Patents)


Location History:

  • Grunewaldstrasse, DE (1999 - 2000)
  • Mainz, DE (1998 - 2005)
  • Constance, DE (2010 - 2015)
  • Stockach, DE (1998 - 2021)

Company Filing History:


Years Active: 1998-2021

Loading Chart...
Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents

Title: Thomas Maier - Innovator in Pharmaceutical Chemistry

Introduction

Thomas Maier, based in Stockach, Germany, is a prominent inventor with a prolific portfolio boasting 45 patents. His contributions particularly shine in the realm of pharmaceutical chemistry, where he focuses on developing novel compounds that hold significant therapeutic potential.

Latest Patents

Among his latest inventions, Maier has made strides in synthesizing crystalline Tafamidis polymorphs. This invention details a new pathway to synthesize these polymorphs starting from a Tafamidis acetic acid adduct. The invention extends to a comprehensive process to create Tafamidis, including its pharmaceutical compositions and therapeutic applications of the new crystalline polymorphs.

Furthermore, Maier's work on substituted imidazoquinolines has opened doors for anticancer treatments. These novel compounds exhibit efficacy as Toll-like Receptor 7 activators, highlighting Maier's commitment to advancing medicine with innovative solutions.

Career Highlights

Throughout his career, Thomas Maier has worked with reputable companies, contributing to the advancement of pharmaceutical innovations. Notably, he has been associated with 4SC AG and American Cyanamid Company. His work in these organizations has fostered significant advancements in drug development and research.

Collaborations

Maier's collaborations are equally noteworthy, particularly with esteemed colleagues such as Stefan Scheiblich and Helmut Siegfried Baltruschat. Together, they have combined their expertise to push the boundaries of pharmaceutical research, leading to impactful breakthroughs in the field.

Conclusion

In conclusion, Thomas Maier stands out as a vital contributor to the world of pharmaceuticals. His innovative approaches to synthesizing new compounds underscore his importance as an inventor. With a robust portfolio and influential collaborations, Maier continues to shape the future of drug development and therapeutic applications, marking him as a key figure in contemporary pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…